Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

DelveInsight's RET Fusion Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report ...

The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval ...

GreensKeeper Value Fund reports a 2025 net return of +0.4% featuring strong gains in Alphabet and American Express. View the ...

The Value Fund returned +0.4% in 2025, facing significant currency headwinds and a concentrated market. Read the full 2025 annual review and portfolio update.